What Is Cystatin C?

What Is Cystatin C?

Cystatin C is a small protein produced continuously by virtually all nucleated cells in the body. It is released into the bloodstream at a steady rate, filtered out by the kidneys, and not secreted or reabsorbed by the renal tubules. This makes it a clean signal of how well the kidneys are filtering blood — a measure known as the glomerular filtration rate (GFR).

Unlike creatinine, cystatin C production is not meaningfully influenced by muscle mass, diet, or physical activity. As a result, it can reflect true kidney function more accurately in populations where creatinine tends to mislead — particularly older adults, people with low muscle mass, or those with muscle-wasting conditions.

In the context of longevity, kidney function matters beyond kidney disease alone. Declining GFR is associated with increased cardiovascular risk, accelerated biological aging, and higher all-cause mortality — even when levels remain within the technically “normal” range. That is why cystatin C has attracted growing attention as a longevity biomarker, not just a nephrology tool. For a broader view of which blood markers are most relevant to healthy aging, see our guide to the most complete longevity blood panel.

Is Cystatin C a Reliable Marker for Kidney Function?

How Accurate Is It?

Research consistently supports cystatin C as a reliable estimator of GFR, particularly in the early stages of kidney function decline. Studies show it correlates well with measured GFR and often detects impairment before creatinine levels rise into abnormal ranges. This is clinically important because early kidney decline frequently goes undetected on standard blood panels.

However, no single marker is perfect. Cystatin C levels can be influenced by thyroid dysfunction, systemic inflammation, corticosteroid use, and obesity — factors that are unrelated to kidney filtration. In these situations, an elevated cystatin C result may not reflect true kidney impairment. This means results should always be interpreted in clinical context, not in isolation.

Is It Better Than Creatinine?

In many contexts, cystatin C adds value over creatinine alone — particularly in older adults and people with low or high muscle mass, where creatinine-based GFR estimates are least reliable. That said, creatinine remains a well-validated, widely available, and cost-effective first-line marker. The two tests are complementary rather than competing. Combining them — as the CKD-EPI 2021 equation does — improves GFR estimation accuracy compared to either marker alone.

For a detailed comparison of how these two markers perform across different populations, see our supporting article on whether cystatin C predicts longevity better than creatinine.

How Is Cystatin C Measured and Interpreted?

The Test

Cystatin C is measured from a standard blood sample using immunoassay techniques available in most clinical laboratories. Results are typically reported as a serum concentration in mg/L, and many labs also use the value to calculate an estimated GFR (eGFR-cys).

Reference Ranges

Most laboratories report normal adult cystatin C levels between approximately 0.53 and 0.95 mg/L, though reference ranges vary slightly by assay method and lab. Elevated levels suggest reduced kidney filtration capacity. Borderline or mildly elevated values — even within the upper end of the reference range — may still carry prognostic significance, particularly in older adults or those with cardiovascular risk factors.

Tracking changes over time is often more informative than a single measurement. A rising trend, even within the reference range, warrants clinical attention alongside other risk markers.

Confounding Factors

Clinicians should be aware that cystatin C can be elevated by hyperthyroidism, high-dose corticosteroid use, and significant systemic inflammation — independent of kidney function. Conversely, hypothyroidism may suppress levels. These factors should be considered before concluding that an abnormal result reflects kidney impairment.

Cystatin C vs Creatinine: How Do They Compare?

Key Differences

Creatinine is a byproduct of muscle metabolism, so its production varies with muscle mass, age, sex, and diet. This means that in a person with low muscle mass — such as a frail older adult — creatinine-based GFR estimates can appear falsely reassuring, overestimating actual kidney function. Cystatin C avoids this problem because its production rate is relatively independent of these variables.

In contrast, creatinine is inexpensive, well-standardised, and has decades of supporting evidence. It remains the default first-line kidney marker in most clinical settings. For most people without specific risk factors, it is adequate for routine monitoring.

When to Use Both

Current evidence supports using both markers together — particularly in older adults, those with unexpectedly low or high muscle mass, and anyone where creatinine-based estimates seem inconsistent with clinical presentation. The combined CKD-EPI equation using both cystatin C and creatinine is generally considered the most accurate non-invasive method for estimating GFR in adults.

From a longevity monitoring perspective, adding cystatin C to a blood panel makes most sense when: age is above 50, creatinine-based eGFR is borderline, or there is a specific concern about early kidney decline that a standard test might miss.

Practical Implications for Longevity and Health Monitoring

Why Kidney Function Matters for Longevity

Even mildly reduced kidney function — well before a diagnosis of chronic kidney disease — is associated with increased cardiovascular risk, higher rates of cognitive decline, and elevated all-cause mortality. This means kidney function is not just a nephrology concern. It is a meaningful signal of systemic health and biological aging.

Research suggests that cystatin C may capture this risk earlier and more precisely than creatinine alone, particularly in older populations. In this sense, it functions as both a kidney marker and a broader indicator of physiological reserve. Learn more in our complete guide to longevity.

Can Lifestyle Affect Cystatin C Levels?

Lifestyle factors that protect kidney function — including good blood pressure control, blood glucose management, reducing systemic inflammation, staying well-hydrated, and avoiding nephrotoxic substances — are likely to support healthy cystatin C levels over time. However, cystatin C is not a marker that responds dramatically to short-term changes. Its primary value is in detecting and tracking kidney function decline, not as a day-to-day lifestyle feedback tool.

That said, addressing the root causes of kidney stress — particularly metabolic dysfunction and chronic low-grade inflammation — remains one of the most actionable ways to protect kidney function long term.

Who Should Test Cystatin C?

Cystatin C is not a necessary first step for everyone. For most people beginning a longevity-focused blood panel, the priority should be covering the core markers: lipids (including ApoB), glucose and insulin sensitivity, inflammation (hs-CRP), liver enzymes, and a standard kidney panel including creatinine and eGFR. Cystatin C adds a meaningful layer for those who are older, have borderline kidney function, have low muscle mass that might distort creatinine-based estimates, or want a more precise picture of kidney health. In these cases, it is a genuinely useful addition rather than an optional novelty.

References and Resources

Frequently Asked Questions

Conclusion

Cystatin C is a well-validated kidney function marker that offers a meaningful advantage over creatinine in specific populations, particularly older adults and those where muscle mass may distort standard estimates. It is not a replacement for creatinine, but rather a complementary tool that can improve GFR accuracy and detect early kidney decline that might otherwise go unnoticed. For longevity-focused blood testing, cystatin C is most valuable as a second-layer marker — useful when standard results are borderline, when precision matters, or when kidney health is a specific concern. It should be interpreted in the context of a complete panel, not as a standalone measurement.